Clinical Trial

Neurostimulation for the Treatment of Post-Stroke Aphasia

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the trial is to determine whether 75Hz transcranial alternating current stimulation (tACS) synchronized with therapeutic linguistic tasks is an effective form of therapy for post-stroke aphasia.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2022-01-04; most recent amendment 2026-02-13.
Status change: Not Yet Recruiting → Recruiting 2022-04-04
Trial Details
NCT Number NCT05194566
Lead Sponsor QVITI S.A.
Collaborators: Icahn School of Medicine at Mount Sinai
Conditions Post-stroke Aphasia
Enrollment 64 participants
Start Date 2023-09-06
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-18